TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Chiesi Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
75,781
|
66,576
|
57,399 |
| Financial expenses |
53
|
21
|
527 |
| Earnings before taxes |
3,968
|
3,092
|
2,770 |
| EBITDA |
4,524
|
3,535
|
3,845 |
| Total assets |
25,498
|
30,721
|
27,445 |
| Current assets |
23,427
|
29,074
|
25,775 |
| Current liabilities |
14,020
|
21,847
|
17,914 |
| Equity capital |
11,478
|
8,873
|
6,533 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
109
|
102
|
98 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.0%
|
28.9%
|
23.8% |
| Turnover per employee |
695
|
653
|
586 |
| Profit as a percentage of turnover |
5.2%
|
4.6%
|
4.8% |
| Return on assets (ROA) |
15.8%
|
10.1%
|
12.0% |
| Current ratio |
167.1%
|
133.1%
|
143.9% |
| Return on equity (ROE) |
34.6%
|
34.8%
|
42.4% |
| Change turnover |
11,468
|
9,010
|
11,845 |
| Change turnover % |
18%
|
16%
|
26% |
| Chg. No. of employees |
7
|
4
|
11 |
| Chg. No. of employees % |
7%
|
4%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.